Omega Healthcare Investors, Inc. $OHI Shares Bought by Amundi

Amundi lifted its holdings in Omega Healthcare Investors, Inc. (NYSE:OHI - Free Report) by 100.4% during the second quarter, according to the company in its most recent filing with the SEC. The fund owned 1,125,875 shares of the real estate investment trust's stock after buying an additional 564,175 shares during the quarter. Amundi owned approximately 0.37% of Omega Healthcare Investors worth $53,682,000 as of its most recent filing with the SEC.

Several other hedge funds and other institutional investors have also modified their holdings of OHI. Resources Management Corp CT ADV lifted its holdings in Omega Healthcare Investors by 300.0% in the fourth quarter. Resources Management Corp CT ADV now owns 600 shares of the real estate investment trust's stock worth $27,000 after acquiring an additional 450 shares during the last quarter. Smartleaf Asset Management LLC boosted its position in Omega Healthcare Investors by 40.9% during the 2nd quarter. Smartleaf Asset Management LLC now owns 924 shares of the real estate investment trust's stock valued at $34,000 after purchasing an additional 268 shares during the period. Ascentis Independent Advisors bought a new position in Omega Healthcare Investors during the 1st quarter worth $35,000. Gunpowder Capital Management LLC dba Oliver Wealth Management bought a new position in Omega Healthcare Investors during the 4th quarter worth $37,000. Finally, Rothschild Investment LLC increased its position in Omega Healthcare Investors by 283.7% in the fourth quarter. Rothschild Investment LLC now owns 944 shares of the real estate investment trust's stock worth $42,000 after buying an additional 698 shares during the period. 65.25% of the stock is owned by institutional investors and hedge funds.

Omega Healthcare Investors Price Performance

Omega Healthcare Investors stock opened at $46.96 on Friday. Omega Healthcare Investors, Inc. has a 12-month low of $39.26 and a 12-month high of $52.39. The stock has a market capitalization of $14.23 billion, a PE ratio of 16.77, a price-to-earnings-growth ratio of 1.91 and a beta of 0.58. The firm has a 50 day simple moving average of $48.19 and a 200-day simple moving average of $47.09.

Omega Healthcare Investors (NYSE:OHI - Get Free Report) last released its earnings results on Wednesday, July 29th. The real estate investment trust reported $1.19 earnings per share for the quarter, topping analysts' consensus estimates of $0.51 by $0.68. The firm had revenue of $328.25 million during the quarter, compared to the consensus estimate of $266.97 million. Omega Healthcare Investors had a return on equity of 15.76% and a net margin of 66.96%.The firm's revenue for the quarter was up 16.2% compared to the same quarter last year. During the same period in the prior year, the firm posted $0.77 earnings per share. Omega Healthcare Investors has set its FY 2026 guidance at 3.220-3.260 EPS. On average, analysts forecast that Omega Healthcare Investors, Inc. will post 3.12 earnings per share for the current fiscal year.

Omega Healthcare Investors Increases Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Friday, August 14th. Stockholders of record on Monday, August 3rd were given a dividend of $0.68 per share. This is a positive change from Omega Healthcare Investors's previous quarterly dividend of $0.67. The ex-dividend date was Monday, August 3rd. This represents a $2.72 annualized dividend and a dividend yield of 5.8%. Omega Healthcare Investors's payout ratio is 97.14%.

Wall Street Analysts Forecast Growth

Several brokerages recently weighed in on OHI. Mizuho lifted their price objective on shares of Omega Healthcare Investors from $45.00 to $46.00 and gave the company a "neutral" rating in a research report on Monday, August 31st. Weiss Ratings upgraded shares of Omega Healthcare Investors from a "buy (b)" rating to a "buy (b+)" rating in a research report on Tuesday, June 30th. Barclays dropped their price target on shares of Omega Healthcare Investors from $51.00 to $50.00 and set an "underweight" rating on the stock in a research note on Monday, August 31st. Scotiabank cut their price target on Omega Healthcare Investors from $50.00 to $47.00 and set a "sector perform" rating on the stock in a report on Thursday, June 18th. Finally, Raymond James Financial assumed coverage on Omega Healthcare Investors in a research report on Tuesday, June 16th. They set an "outperform" rating and a $50.00 price objective for the company. Six analysts have rated the stock with a Buy rating, seven have issued a Hold rating and two have issued a Sell rating to the company. According to data from MarketBeat, the stock presently has a consensus rating of "Hold" and a consensus target price of $49.50.

About Omega Healthcare Investors

Omega Healthcare Investors, Inc NYSE: OHI is a real estate investment trust focused on the healthcare sector. The company owns and leases healthcare-related real estate, with an emphasis on facilities that provide long-term and post-acute care.

Omega's portfolio is primarily made up of skilled nursing facilities and assisted living facilities. It generally leases these properties to healthcare operators under long-term, often triple-net lease arrangements, under which tenants are typically responsible for property-level expenses such as maintenance, insurance and taxes.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.